The CARBALIVE Consortium announces positive results of a Phase 2 equivalent trial of engineered macroporous carbons as a novel treatment for cirrhosis. carbalive.eu
EU Commissioner for Research, Science and Innovation mentions CARBALIVE: elpa.eu/news/jun-2017/commis…
NASH-NAFLD Summit-31st May 2017
CARBALIVE project featured in The Sunday Times - thetimes.co.uk/article/tiny-…
CARBALIVE retweeted
called #Yaq-001. Brighton university, Mast Carbon are also inventors. Funded by EU grant. Develop by #Yaqrit. xitter.cf/usabilityliz/status/64… – at Bromley, London
Hope for #cirrhosis patients. New drug being tested to filter toxins from body by @RajivJalan1 and team: dailym.ai/1KTaPwm #research


